Abbott Laboratories
ABT
$106.86
-$0.03-0.03%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.28B | 7.05B | 8.16B | 9.53B | 10.17B |
| Total Receivables | 6.57B | 6.50B | 6.17B | 6.02B | 6.22B |
| Inventory | 6.57B | 6.65B | 6.87B | 6.67B | 6.17B |
| Prepaid Expenses | 2.09B | 2.10B | 2.08B | 2.00B | 2.25B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 169.00M | 367.00M | 225.00M | 154.00M | 412.00M |
| Total Current Assets | 22.67B | 22.66B | 23.51B | 24.38B | 25.22B |
|
|
|||||
| Total Current Assets | 22.67B | 22.66B | 23.51B | 24.38B | 25.22B |
| Net Property, Plant & Equipment | 11.28B | 9.55B | 9.45B | 9.28B | 10.28B |
| Long-term Investments | 23.68B | 23.28B | 23.26B | 22.93B | 22.80B |
| Goodwill | 23.68B | 23.28B | 23.26B | 22.93B | 22.80B |
| Total Other Intangibles | 8.82B | 9.28B | 9.83B | 10.01B | 10.45B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.29B | 6.82B | 6.81B | 6.73B | 5.22B |
| Total Assets | 73.21B | 72.09B | 73.35B | 73.79B | 74.44B |
|
|
|||||
| Total Accounts Payable | 4.30B | 3.96B | 4.21B | 4.17B | 4.61B |
| Total Accrued Expenses | 6.54B | 6.64B | 6.51B | 6.62B | 6.93B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.33B | 1.06B | 2.28B | 2.29B | 2.50B |
| Total Finance Division Other Current Liabilities | 1.68B | 1.38B | 1.35B | 1.46B | 1.46B |
| Total Other Current Liabilities | 1.68B | 1.38B | 1.35B | 1.46B | 1.46B |
| Total Current Liabilities | 13.84B | 13.04B | 14.35B | 14.53B | 15.49B |
|
|
|||||
| Total Current Liabilities | 13.84B | 13.04B | 14.35B | 14.53B | 15.49B |
| Long-Term Debt | 13.60B | 14.64B | 14.70B | 14.74B | 14.52B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 949.00M | -- | -- | -- | 943.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.00B | 6.72B | 6.90B | 7.29B | 6.58B |
| Total Liabilities | 34.39B | 34.40B | 35.95B | 36.56B | 37.53B |
|
|
|||||
| Common Stock & APIC | 24.87B | 24.73B | 24.61B | 24.49B | 24.71B |
| Retained Earnings | 37.55B | 36.92B | 36.36B | 35.87B | 35.26B |
| Treasury Stock & Other | -23.82B | -24.17B | -23.79B | -23.35B | -23.28B |
| Total Common Equity | 38.60B | 37.48B | 37.17B | 37.01B | 36.69B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 38.60B | 37.48B | 37.17B | 37.01B | 36.69B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 224.00M | 213.00M | 230.00M | 222.00M | 219.00M |
| Total Equity | 38.83B | 37.69B | 37.40B | 37.23B | 36.91B |
|
|
|||||
